Gene · 359
Papers3,878
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,878
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Following the cellular itinerary of renal aquaporin-2 shuttling with 4.5x expansion microscopy. | Am J Physiol Cell Physiol | 2024 | 38047301 | PubTator, text mining | PubMed |
| Effect of a moderate alcohol dose on physiological responses during rest and prolonged cycling. | Alcohol Alcohol | 2024 | 37981293 | PubTator, text mining | PubMed |
| Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct. | Am J Physiol Renal Physiol | 2024 | 37916285 | PubTator, text mining | PubMed |
| Bioinformatics-guided disproportionality analysis of sevoflurane-induced nephrogenic diabetes insipidus using the FDA Adverse Event Reporting System database. | Br J Clin Pharmacol | 2024 | 37536932 | PubTator, text mining | PubMed |
| Many kinases for controlling the water channel aquaporin-2. | J Physiol | 2024 | 37440212 | PubTator, text mining | PubMed |
| 'Aquaporin-omics': mechanisms of aquaporin-2 loss in polyuric disorders. | J Physiol | 2024 | 37114282 | PubTator, text mining | PubMed |
| Identification of protein kinase A signalling molecules in renal collecting ducts. | J Physiol | 2024 | 37013848 | PubTator, text mining | PubMed |
| Novel signalling pathways in nephrogenic syndrome of inappropriate antidiuresis: functional implication of site-specific AQP2 phosphorylation. | J Physiol | 2024 | 36823952 | PubTator, text mining | PubMed |
| Proteomics and AQP2 regulation. | J Physiol | 2024 | 36571566 | PubTator, text mining | PubMed |
| Case report: abemaciclib-induced syndrome of inappropriate antidiuretic hormone (SIADH) without underlying kidney injury in a patient with early-stage estrogen receptor (ER)+ breast cancer. | Front Med (Lausanne) | 2023 | 38293306 | PubTator, text mining | PubMed |
| Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD. | Front Endocrinol (Lausanne) | 2023 | 38288467 | PubTator, text mining | PubMed |
| Effect of TMAO on the incidence and prognosis of cerebral infarction: a systematic review and meta-analysis. | Front Neurol | 2023 | 38259655 | PubTator, text mining | PubMed |
| Aquaporin Expression and Regulation in Clinical and Experimental Sepsis. | Int J Mol Sci | 2023 | 38203657 | PubTator, text mining | PubMed |
| Unraveling the Multifaceted Roles of Extracellular Vesicles: Insights into Biology, Pharmacology, and Pharmaceutical Applications for Drug Delivery. | Int J Mol Sci | 2023 | 38203656 | PubTator, text mining | PubMed |
| Acid base homeostasis and serum bicarbonate concentration in syndrome of inappropriate anti-diuretic hormone secretion (SIADH) with hyponatremia. | Front Endocrinol (Lausanne) | 2023 | 38144560 | PubTator, text mining | PubMed |
| Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development. | Pharmaceuticals (Basel) | 2023 | 38139776 | PubTator, text mining | PubMed |
| Controlled Plasma Membrane Delivery of FGFR1 and Modulation of Signaling by a Novel Regulated Anterograde RTK Transport Pathway. | Cancers (Basel) | 2023 | 38136383 | PubTator, text mining | PubMed |
| Genomic Fabrics of the Excretory System's Functional Pathways Remodeled in Clear Cell Renal Cell Carcinoma. | Curr Issues Mol Biol | 2023 | 38132440 | PubTator, text mining | PubMed |
| Sleep and circadian rhythm disturbance in kidney stone disease: a narrative review. | Front Endocrinol (Lausanne) | 2023 | 38089624 | PubTator, text mining | PubMed |
| Roles and regulation of Aquaporin-3 in maintaining the gut health: an updated review. | Front Physiol | 2023 | 38089478 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/359/papers?page=8